Deep learning enabled liquid-based cytology model for cervical precancer and cancer detection.
other
Where this comes from
- Record sourced from PubMed, PMID 40222978.
- Also identified by DOI 10.1038/s41467-025-58883-3 and PMC identifier 11994794.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Deep learning (DL) enabled liquid-based cytology has potential for cervical cancer screening or triage. Here, we develop a DL model using whole cytology slides from 17,397 women and test it on 10,826 additional cases through a three-stage process. The DL model achieves robust performance across nine hospitals. In a multi-reader, multi-case study, it outperforms cytopathologists' sensitivity by 9%. Reading time significantly decreases with DL assistance (218s vs 30s; p < 0.0001). In community-based organized screening, the DL model's sensitivity matches that of senior cytopathologists (0.878 vs 0.854; p > 0.999), yet it has reduced specificity (0.831 vs 0.901; p < 0.0001). Notably, hospital-based opportunistic screening shows that junior cytopathologists with DL assistance significantly improve both their sensitivity and specificity (0.857 vs 0.657, 0.840 vs 0.737; both p < 0.0001). When triaging human papillomavirus-positive cases, DL assistance exhibits better performance than junior cytopathologists alone. These findings support using the DL model as an assistance tool in cervical screening and case triage.
Medical subject headings
- Deep Learning
- Uterine Cervical Neoplasms
- Early Detection of Cancer
- Precancerous Conditions
- Cytodiagnosis